Clariant's Catalysts business has formed an alliance with clean energy company, Hydrogenious Technologies, to provide reliable, scalable and safe hydrogen supply solutions for a wide variety of applications.

Plant construction without annoying interfaces — There are not many technology and plant construction firms who can cover the full range of engineering services. But the EPC Group can! PROCESS visited the traditional — yet highly innovative — company from Thüringen/Germany.

In today’s world of fierce competition and tough regulatory compliance pressure, to remain competitive with hassle-free production, every biopharmaceutical manufacturer is looking at some key catalysts of process change – such as modularisation, flexibility, fast changeover and minimising contamination risks. Thus, technologies engrossing this paradigm shift are coming into the forefront. Rapid advancement in disposable technologies will soon make them indispensable.

The Thyssenkrupp Group’s materials business is digitizing its entire range and consolidating it in what the company describes as the world’s biggest virtual warehouse.

The emerging Asian Middle classes, urbanisation and population grow drive the need for environemntal solutions, esepcially for clean and sustainable water, in the developing countries - adevelopment that was of major interest at this year's IFAT India 2013...

Lanxess is expanding cresol production at its Leverkusen site once again. The specialty chemicals company plans to further increase capacity for this high-quality intermediate for the global market by some 20 percent by mid 2013.

Clariant has been awarded a contract by Jinneng Science & Technology Company, to design the world’s largest single-train propane dehydrogenation unit in collaboration with CB&I.

Continuous manufacturing is nowadays one of the main drivers of innovation in the pharmaceutical industry. Strongly encouraged by the regulatory authorities for drug production, continuous manufacturing can ensure flexible and efficient production, while improving the pharmaceutical products in terms of potency, effectiveness and safety.

Linde Bangladesh, a subsidiary of The Linde Group’s Gases Division, will invest €14.6 million in Rupganj to build an air separation unit (ASU) producing approximately 100 tonnes per day of liquefied gases, making it the largest liquid producing ASU in Bangladesh.

Biopharmaceutical manufacturing may come in a wide variety of forms, but every iteration of unit operation must adhere to an unbending set of operational parameters and structures if the desired outcome — a viable, contaminant-free drug suitable for human or animal administration — is to be realized. It is all about “controlled fluid transfer.”